Alcami enhances analytical services in Edison, NJ

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Ca-ssis)
(Image: iStock/Ca-ssis)
The latest in a series of investments, Alcami has strengthened its analytical services capabilities at its Edison, New Jersey-based site.

The CDMO offers comprehensive chemistry, environmental, and microbial capabilities at the facilities, in addition to multi-compendial testing and customized analysis.

According to the company, the Edison site is capable of meeting FDA requirements for Antibiotic Analysis both using USP < 81 > and can perform bridging analysis to an alternative method per USP < 1223.1 >. 

Additionally, Alcami has added​ 2,000 cubic feet of stability chamber space across its network, new control systems for all chambers, and a REES environmental monitoring system.

The company is also working to adopt Lean principles at its laboratories, a process which is said will be completed in 2017.

Alcami did not respond to a request for comment.

Related news

Show more

Related products

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...


Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...


Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers